Blake Lauren Walsh
Blake Walsh joined as an associate in the firm's Washington, DC office in 2015. She has experience advising health care clients on a broad spectrum of regulatory, life sciences and other transactional matters. Blake focuses her practice on advising medical device, pharmaceutical and health technology companies on complex licensing and collaboration arrangements.
Blake's regulatory experience includes advising clients on various operational matters, including compliance with both federal and state-specific fraud and abuse laws, HIPAA, EMTALA, Medicare/Medicaid reimbursement, corporate practice of medicine prohibitions, certificate of need requirements, and health care professional scope of practice issues. Blake has assisted hospital systems, physician practice groups and pharmacies in transactional matters, including conducting relevant health care regulatory due diligence and transitioning licenses, permits, and accreditations between entities in connection with changes in ownership.
JD, magna cum laude, Order of the Coif, University of Maryland Carey School of Law, 2014
BA, History of Science and Medicine, Yale University, 2009
While in law school, Blake served as President of the Student Health Law Organization and Articles Editor on the Maryland Law Review.
- District of Columbia Bar
- Tennessee State Bar
Memberships and activities
- Tennessee State Bar Association
- Nashville Bar Association
- Maryland State Bar Association
- American Health Lawyers Association
During law school, Blake participated in a free legal clinic, assisting HIV-positive individuals with child custody matters, Social Security disability appeals, and preparing advance directives
Norton Rose Fulbright advised Shionogi & Co. and Purdue Pharma L.P. in an alliance for the joint US launch and commercialization of Symproic®..
December 21, 2016